For instance, RGC-32 exerts a tumor-suppressive effect in lung adenocarcinomas with wild-type TP53, but a tumor-promoting effect in the tumors carrying TP53 mutations (98). The gene discussed is TP53; the disease is lung adenocarcinoma.